AD-214 clinical trials
Also written AD-214.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How each study uses AD-214 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AD-214
- 3
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
AdAlta Limited (2) · Addpharma Inc. (1)
Often tested with
Tested in the same studies.
AD-2141 (1)
Studies
Open first, then newest update. How each study uses AD-214 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney DiseaseCompletedPhase 1AdAlta LimitedNCT05914909Written as AD-214How we know
- A Study to Compare PK, PD and Safety of the AD-214 and AD-2141CompletedPhase 1Addpharma Inc.NCT05062876Written as AD-214How we know
- Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy VolunteersCompletedPhase 1AdAlta LimitedNCT04415671Written as AD-214How we know